Viewing data from:

CALCITRIOL

ANDA

CALCITRIOL | A091174 | BIONPHARMA INC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: ROCALTROL(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.2516

per ea

Lowest NADAC/Unit

$0.1607

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69452020820CALCITRIOL 0.5 MCG CAPSULE	$0.2516	EA	Generic	—	2026-06-17
69452020713CALCITRIOL 0.25 MCG CAPSULE	$0.1607	EA	Generic	—	2026-06-17
69452020720CALCITRIOL 0.25 MCG CAPSULE	$0.1607	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$7.97

Highest Price

$24.36

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
69452-0207-13CALCITRIOL 0.25MCG CAP	$7.97	FSS	Golden State Medical Supply, Inc.	06/14/2028
51407-0169-01CALCITRIOL 0.25MCG CAP	$12.91	FSS	Golden State Medical Supply, Inc.	06/14/2028
51407-0170-01CALCITRIOL 0.5MCG CAP	$24.36	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain5 active DMFs3 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

TAPI NL BVCALCITRIOL USP

DMF 124171997

CARBOGEN AMCIS BVCALCITRIOL

DMF 140931999

CERBIOS PHARMA SACALCITRIOL

DMF 147182000

MICROBIOPHARM JAPAN CO LTDCALCITRIOL

DMF 151282000

FORMOSA LABORATORIES INCCALCITRIOL

DMF 182272005

DUPHAR BVInactiveCALCITRIOL

DMF 65471986

SAFC INCInactiveCALCITRIOL, EP

DMF 159812002

CATALENT PHARMA SOLUTIONS LLCInactiveCALCITRIOL 0.25 MCG SOFT GELATIN CAPSULES

DMF 169742003

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 0.25MCG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: May 24, 2013

No patent or exclusivity listings for this strength.

#002 — 0.5MCG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: May 24, 2013